RGS9 Antibodies

Santa Cruz Biotechnology offers a broad range of RGS9 monoclonal antibodies for research focused on understanding RGS9 protein functions. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RGS9, or Regulator of G Protein Signaling 9, plays a critical role in modulating G protein signaling pathways, particularly in the nervous system. RGS9 is involved in processes such as neurotransmission and signal transduction, making it essential for normal brain function and behavior. Dysregulation of RGS9 has been implicated in various neurological disorders, highlighting its importance as a target for therapeutic intervention. Researchers can explore RGS9's cellular distribution patterns through immunofluorescence (IF) studies. Flow cytometry (FCM) analysis enables quantitative measurement of RGS9 expression levels in different cell populations. Western blotting (WB) experiments help determine RGS9 protein size and expression. Immunohistochemistry with paraffin-embedded sections (IHCP) reveals RGS9's tissue localization patterns. Santa Cruz Biotechnology monoclonal antibodies for RGS9 support researchers worldwide in advancing neuroscience and developing potential therapeutic strategies for neurological conditions.